Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Reprod Immunol. 2015 Apr 22;110:14–21. doi: 10.1016/j.jri.2015.03.007

Figure 1.

Figure 1

Cytokine concentrations in cervicovaginal lavages (CVLs) from women using injectable HCs (DMPA or Net-EN) compared to those not using HCs, stratified according to presence of discharge causing STIs (C. trachomatis, N. gonnorhoea, M. genitalium; GCM). Dotted lines indicate the median concentration of each cytokine, MMP or TIMP in women not using HCs and who were GCM negative, as the reference group. ** indicates significant interactions between injectable HC use and GCM with p<0.05, while * indicates interactions between injectable HC use and GCM with p<0.10.